Policy

• Health & Medicine

‘Levelling Up’: What should it mean for cancer?

The UK Government has set out how they'll help parts of the country to catch up on a range of measures, including health. The UK Government has set out how they'll help parts of the country to catch up on a range of measures, including health.

2 February 2022

• Health & Medicine

Immunotherapy treatment fast tracked to treat lung cancer patients in England

Hope for patients with early-stage lung cancer as new treatment approved for use on NHS England. Hope for patients with early-stage lung cancer as new treatment approved for use on NHS England.

28 January 2022

• Science & Technology
• For Researchers

Seven Centres to form new Cancer Research UK network

From 1 April, we’re investing £100 million over five years into seven Cancer Research UK Centres across the UK. From 1 April, we’re investing £100 million over five years into seven Cancer Research UK Centres across the UK.

24 January 2022

• Health & Medicine
• Charity News

Cancer Research UK publishes gender and ethnicity pay gap reports

The charity publishes its gender and ethnicity pay gap reports. The charity publishes its gender and ethnicity pay gap reports.

20 January 2022

• Health & Medicine

Ovarian, bowel and non-Hodgkin's lymphoma treatments approved for NHS use in Scotland

Three new treatment options made available for cancer patients in Scotland. Three new treatment options made available for cancer patients in Scotland.

16 December 2021

• Health & Medicine

How will new cancer medicines be approved in the future?

In the last decade, many more cancer drugs have become available compared to what we’ve seen previously. This has led to more cancer treatment options, but it has also led to more uncertainty about drugs’ clinical benefit and cost-effectiveness. How can this be addressed? In the last decade, many more cancer drugs have become available compared to what we’ve seen previously. This has led to more cancer treatment options, but it has also led to more uncertainty about drugs’ clinical benefit and cost-effectiveness. How can this be addressed?

2 December 2021

• Health & Medicine

Targeted drug recommended to treat some advanced lung cancer patients

Selpercatinib will expand treatment options available for people with RET fusion positive non small cell lung cancer on the NHS in England. Selpercatinib will expand treatment options available for people with RET fusion positive non small cell lung cancer on the NHS in England.

25 November 2021

• Health & Medicine
• Policy & Insight

“That is what I dream”: India’s journey to rolling out the HPV vaccine

We spoke to Dr Ishu Kataria who works with WHO to prevent the spread of infections like HPV, which causes 99% of cervical cancers worldwide. We spoke to Dr Ishu Kataria who works with WHO to prevent the spread of infections like HPV, which causes 99% of cervical cancers worldwide.

17 November 2021

• For Researchers

The director’s cut: How Dr Catherine Elliott sees the future of cancer research

We caught up with Director of Research, Dr Catherine Elliott, to talk pandemic recovery, research careers and the role of curiosity in a goal driven scientific environment We caught up with Director of Research, Dr Catherine Elliott, to talk pandemic recovery, research careers and the role of curiosity in a goal driven scientific environment

2 November 2021

• For Researchers

What the Budget 2021 means for research

The Comprehensive Spending Review has set out the Government’s spending plans for the next three years - but what do these plans mean for our research community and its work? The Comprehensive Spending Review has set out the Government’s spending plans for the next three years - but what do these plans mean for our research community and its work?

29 October 2021